Senseonics Holdings, Inc. (SENS)

Market Cap	391.05M
Revenue (ttm)	22.47M
Net Income (ttm)	-78.62M
Shares Out	651.85M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,752,890
Open	0.5927
Previous Close	0.5941
Day's Range	0.5894 - 0.6150
52-Week Range	0.2500 - 1.4000
Beta	0.86
Analysts	Strong Buy
Price Target	2.00 (+228.52%)
Earnings Date	May 12, 2025

About SENS

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company’s products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. It se...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 117
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: SENS
• Website: https://www.senseonics.com

Financial Performance

In 2024, Senseonics Holdings's revenue was $22.47 million, an increase of 0.37% compared to the previous year's $22.39 million. Losses were -$78.62 million, 30.2% more than in 2023.

Analyst Forecast

According to 2 analysts, the average rating for SENS stock is "Strong Buy." The 12-month stock price forecast is $2.0, which is an increase of 228.52% from the latest price.

Price Target

$2.0

(228.52% upside)

Analyst Consensus: Strong Buy